Brucella melitensis

A comprehensive overview of Brucella melitensis

Overview

Brucella melitensis is a Gram-negative bacterium that is one of the causative agents of brucellosis, a zoonotic infection that primarily affects sheep and goats. It is highly pathogenic and can also infect humans, leading to a febrile illness known as undulant fever.

File:BrucellaMelitensis.jpg

Brucella melitensis under a microscope

Morphology and Characteristics

Brucella melitensis is a small, non-motile, coccobacillus. It is an aerobic organism that does not form spores. The bacterium is characterized by its ability to survive and replicate within macrophages, which are cells of the immune system that typically engulf and destroy pathogens.

Pathogenesis

The pathogenesis of Brucella melitensis involves its ability to invade and survive within host cells. Upon entering the body, the bacteria are phagocytosed by macrophages. However, instead of being destroyed, B. melitensis can manipulate the host cell's environment to avoid destruction and replicate within the phagosome. This intracellular lifestyle allows the bacteria to evade the host's immune response and establish a chronic infection.

Transmission

Brucella melitensis is primarily transmitted to humans through direct contact with infected animals or consumption of contaminated animal products, such as unpasteurized milk and cheese. Inhalation of aerosols containing the bacteria can also lead to infection, which is a concern in laboratory settings and among individuals working in close proximity to infected animals.

Clinical Manifestations

In humans, infection with Brucella melitensis can lead to a range of symptoms, including fever, sweats, malaise, anorexia, headache, and muscle pain. The disease can become chronic, with symptoms persisting for months or even years if not properly treated. Complications can include arthritis, endocarditis, and neurological disorders.

Diagnosis

Diagnosis of Brucella melitensis infection is typically made through serological tests that detect antibodies against the bacteria. Blood cultures can also be used to isolate the organism, although this method is less commonly employed due to the slow-growing nature of the bacteria and the risk of laboratory-acquired infections.

Treatment

The treatment of brucellosis caused by Brucella melitensis involves a combination of antibiotics. The most commonly used regimen includes doxycycline and rifampin for a duration of at least six weeks. In severe cases, additional antibiotics such as streptomycin or gentamicin may be added to the treatment regimen.

Prevention

Preventive measures include the vaccination of livestock, pasteurization of dairy products, and the use of protective equipment by individuals at risk of exposure. Public health education and control programs are essential in reducing the incidence of brucellosis in endemic areas.

Related pages

• Brucellosis
• Zoonosis
• Gram-negative bacteria
• Macrophage

Brucella melitensis

• 
  Brucella melitensis under microscope
• Endoscopic view of Brucella infection
  Endoscopic view of Brucella infection